表紙:関節内補充療法の世界市場:製品(5回注射、単回注射、3回注射)別の予測(2026年まで)- COVID-19の累積的影響
市場調査レポート
商品コード
1001099

関節内補充療法の世界市場:製品(5回注射、単回注射、3回注射)別の予測(2026年まで)- COVID-19の累積的影響

Viscosupplementation Market Research Report by Product (Five Injection, Single Injection, and Three Injection), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 185 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
関節内補充療法の世界市場:製品(5回注射、単回注射、3回注射)別の予測(2026年まで)- COVID-19の累積的影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の関節内補充療法の市場規模は、2020年の23億9,451万米ドルから、2025年末までに30億7,705万米ドルに拡大すると予想されています。

COVID-19は、ほぼすべての業界に影響を与えた未曾有の世界の公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されています。当レポートでは、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げ消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19の影響について考察しています。

当レポートは、世界の関節内補充療法市場について調査しており、市場の機会や課題、成長および抑制要因、COVID-19の累積的影響、製品・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査期間
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査設計
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画を作成する
    • 実行:調査を実施する
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • 市場展望
  • 製品別市場の展望
  • 地域別市場の展望
  • 競合他社の見通し

第4章 市場概要

  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターのファイブフォース分析

第6章 製品別市場

  • 5回注射
  • 単回注射
  • 3回注射

第7章 南北アメリカ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第8章 アジア太平洋地域市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第9章 欧州、中東・アフリカ市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第10章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併・買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第11章 企業プロファイル

  • Alcon Vision LLC
  • Allergan, Inc.
  • Anika Therapeutics, Inc.
  • Bausch Health Companies Inc
  • Bioventus LLC
  • Chugai Pharmaceutical Co., Ltd.
  • Contipro A.S.
  • F. Hoffmann-La Roche AG
  • Ferring B.V.
  • Fidia Farmaceutici S.P.A.
  • Galderma Laboratories, L.P.
  • Johnson & Johnson Services, Inc
  • LG Life Sciences Ltd
  • Lifecore Biomedical, LLC
  • Mylan N.V.
  • OrthogenRx, Inc
  • Regen Lab SA
  • Salix Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Seikagaku Corporation
  • Smith & Nephew Plc
  • Teva Pharmaceutical Industries Ltd
  • Zimmer Biomet

第12章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET: MARKET DYNAMICS
  • FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 8. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, 2018-2026 (USD MILLION)
  • FIGURE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 16. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 18. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 19. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 20. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 21. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 22. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 23. CALIFORNIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 24. FLORIDA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 25. ILLINOIS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 26. NEW YORK VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 27. OHIO VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 28. PENNSYLVANIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 29. TEXAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 30. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 31. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 33. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 42. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 44. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. GLOBAL VISCOSUPPLEMENTATION MARKET: FPNV POSITIONING MATRIX
  • FIGURE 56. GLOBAL VISCOSUPPLEMENTATION MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 57. GLOBAL VISCOSUPPLEMENTATION MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 58. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VISCOSUPPLEMENTATION MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL VISCOSUPPLEMENTATION MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. CALIFORNIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. FLORIDA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. ILLINOIS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. NEW YORK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. OHIO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. PENNSYLVANIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. TEXAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. GLOBAL VISCOSUPPLEMENTATION MARKET: SCORES
  • TABLE 46. GLOBAL VISCOSUPPLEMENTATION MARKET: BUSINESS STRATEGY
  • TABLE 47. GLOBAL VISCOSUPPLEMENTATION MARKET: PRODUCT SATISFACTION
  • TABLE 48. GLOBAL VISCOSUPPLEMENTATION MARKET: RANKING
  • TABLE 49. GLOBAL VISCOSUPPLEMENTATION MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 50. GLOBAL VISCOSUPPLEMENTATION MARKET: SHARE, BY COMPANY, 2020
  • TABLE 51. GLOBAL VISCOSUPPLEMENTATION MARKET: MERGER & ACQUISITION
  • TABLE 52. GLOBAL VISCOSUPPLEMENTATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 53. GLOBAL VISCOSUPPLEMENTATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 54. GLOBAL VISCOSUPPLEMENTATION MARKET: INVESTMENT & FUNDING
  • TABLE 55. GLOBAL VISCOSUPPLEMENTATION MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 56. GLOBAL VISCOSUPPLEMENTATION MARKET: LICENSE & PRICING
  • TABLE 57. GLOBAL VISCOSUPPLEMENTATION MARKET: CONTACT DETAILS
目次
Product Code: MRR-0315DDADCE20

The Global Viscosupplementation Market size was estimated at USD 2,394.51 Million in 2020 and expected to reach USD 2,529.65 Million in 2021, at a Compound Annual Growth Rate (CAGR) 5.98% to reach USD 3,393.24 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Viscosupplementation to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Viscosupplementation Market was studied across Five Injection, Single Injection, and Three Injection.

Based on Geography, the Viscosupplementation Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Viscosupplementation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Viscosupplementation Market, including Alcon Vision LLC, Allergan, Inc., Anika Therapeutics, Inc., Bausch Health Companies Inc, Bioventus LLC, Chugai Pharmaceutical Co., Ltd., Contipro A.S., F. Hoffmann-La Roche AG, Ferring B.V., Fidia Farmaceutici S.P.A., Galderma Laboratories, L.P., Johnson & Johnson Services, Inc, LG Life Sciences Ltd, Lifecore Biomedical, LLC, Mylan N.V., OrthogenRx, Inc, Regen Lab SA, Salix Pharmaceuticals, Inc., Sanofi S.A., Seikagaku Corporation, Smith & Nephew Plc, Teva Pharmaceutical Industries Ltd, and Zimmer Biomet.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Viscosupplementation Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Viscosupplementation Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Viscosupplementation Market?
  • 4. What is the competitive strategic window for opportunities in the Global Viscosupplementation Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Viscosupplementation Market?
  • 6. What is the market share of the leading vendors in the Global Viscosupplementation Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Viscosupplementation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. Geography Outlook
  • 3.5. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for non-surgical treatment for osteoarthritis
      • 5.1.1.2. Rising occurrence of lifestyle-induced disorders with changing eating habits
      • 5.1.1.3. Surge in geriatric population and obesity globally
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of efficiency and product safety
      • 5.1.2.2. High cost of the hyaluronic acid-based treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in the development of hyaluronic acid-based therapies
      • 5.1.3.2. Increasing research and development for product expansion
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory mandates for approval coupled with short duration of lubrication and pain relief
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Viscosupplementation Market, by Product

  • 6.1. Introduction
  • 6.2. Five Injection
  • 6.3. Single Injection
  • 6.4. Three Injection

7. Americas Viscosupplementation Market

  • 7.1. Introduction
  • 7.2. Argentina
  • 7.3. Brazil
  • 7.4. Canada
  • 7.5. Mexico
  • 7.6. United States
    • 7.6.1. California
    • 7.6.2. Florida
    • 7.6.3. Illinois
    • 7.6.4. New York
    • 7.6.5. Ohio
    • 7.6.6. Pennsylvania
    • 7.6.7. Texas

8. Asia-Pacific Viscosupplementation Market

  • 8.1. Introduction
  • 8.2. China
  • 8.3. India
  • 8.4. Indonesia
  • 8.5. Japan
  • 8.6. Malaysia
  • 8.7. Philippines
  • 8.8. South Korea
  • 8.9. Thailand

9. Europe, Middle East & Africa Viscosupplementation Market

  • 9.1. Introduction
  • 9.2. France
  • 9.3. Germany
  • 9.4. Italy
  • 9.5. Netherlands
  • 9.6. Qatar
  • 9.7. Russia
  • 9.8. Saudi Arabia
  • 9.9. South Africa
  • 9.10. Spain
  • 9.11. United Arab Emirates
  • 9.12. United Kingdom

10. Competitive Landscape

  • 10.1. FPNV Positioning Matrix
    • 10.1.1. Quadrants
    • 10.1.2. Business Strategy
    • 10.1.3. Product Satisfaction
  • 10.2. Market Ranking Analysis
  • 10.3. Market Share Analysis, By Quadrant
  • 10.4. Market Share Analysis, By Company
  • 10.5. Competitive Scenario
    • 10.5.1. Merger & Acquisition
    • 10.5.2. Agreement, Collaboration, & Partnership
    • 10.5.3. New Product Launch & Enhancement
    • 10.5.4. Investment & Funding
    • 10.5.5. Award, Recognition, & Expansion

11. Company Usability Profiles

  • 11.1. Alcon Vision LLC
  • 11.2. Allergan, Inc.
  • 11.3. Anika Therapeutics, Inc.
  • 11.4. Bausch Health Companies Inc
  • 11.5. Bioventus LLC
  • 11.6. Chugai Pharmaceutical Co., Ltd.
  • 11.7. Contipro A.S.
  • 11.8. F. Hoffmann-La Roche AG
  • 11.9. Ferring B.V.
  • 11.10. Fidia Farmaceutici S.P.A.
  • 11.11. Galderma Laboratories, L.P.
  • 11.12. Johnson & Johnson Services, Inc
  • 11.13. LG Life Sciences Ltd
  • 11.14. Lifecore Biomedical, LLC
  • 11.15. Mylan N.V.
  • 11.16. OrthogenRx, Inc
  • 11.17. Regen Lab SA
  • 11.18. Salix Pharmaceuticals, Inc.
  • 11.19. Sanofi S.A.
  • 11.20. Seikagaku Corporation
  • 11.21. Smith & Nephew Plc
  • 11.22. Teva Pharmaceutical Industries Ltd
  • 11.23. Zimmer Biomet

12. Appendix

  • 12.1. Discussion Guide
  • 12.2. License & Pricing
  • 12.3. Contact Details